CNC vs TCRT · P/E 8.4, rev $103.52B vs $5.6M cap
Centene Corp (CNC) versus Alaunos Therapeutics Inc (TCRT) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. TCRT currently screens at market cap $5.6M.
Not investment advice. Open the CNC and TCRT stock pages for the full models.
Not investment advice.